PMID- 25095762 OWN - NLM STAT- MEDLINE DCOM- 20160609 LR - 20220321 IS - 1724-6059 (Electronic) IS - 1121-8428 (Linking) VI - 28 IP - 5 DP - 2015 Oct TI - Homocysteine, cysteine, folate and vitamin B(1)(2) status in type 2 diabetic patients with chronic kidney disease. PG - 571-6 LID - 10.1007/s40620-014-0126-4 [doi] AB - BACKGROUND: Hyperhomocysteinemia (hHcy) is a risk factor in the progression of chronic kidney disease (CKD). In type 2 diabetes (T2D), hHcy is strongly associated with increased risk of cardiovascular disease. Vitamin B12 and folic acid supplementation have been reported to lower homocysteine (tHcy) levels, but no data on plasma tHcy, cysteine (Cys), folate and vitamin B12 levels in T2D-CKD patients are reported. PROCEDURES: tHcy and Cys levels were analyzed in 178 T2D-CKD patients by high performance liquid chromatography (HPLC) with fluorescence detection. In addition, we determined folate and vitamin B12 levels using a chemiluminescence method. RESULTS: tHcy and Cys levels were increased in T2D patients, and this rise positively correlated with the CKD stage (P < 0.001). Folate levels were comparable to controls at various CKD stages, whereas vitamin B12 levels were lower, except at stage IV. We did not find any correlation between B-vitamins and levels of tHcy and Cys, regardless of the CKD stage. CONCLUSIONS: This is the first study reporting tHcy, Cys and B-vitamins status in T2D-CKD patients. Although limited to our cohort of 178 patients, our findings could be helpful in clarifying the conflicting literature regarding B-vitamins supplementation. Further studies are necessary before any Hcy-lowering therapy can be safely established in T2D-CKD subjects. FAU - Pastore, Anna AU - Pastore A AD - Metabolomic and Proteomic Unit, Children's Hospital "Bambino Gesu", IRCCS, P.zza S. Onofrio, 4, 00165, Rome, Italy. anna.pastore@opbg.net. FAU - Noce, Annalisa AU - Noce A AD - Department of Internal Medicine, Nephrology and Hypertension Unit, "Tor Vergata" University Hospital, Rome, Italy. FAU - Di Giovamberardino, Gianna AU - Di Giovamberardino G AD - Metabolomic and Proteomic Unit, Children's Hospital "Bambino Gesu", IRCCS, P.zza S. Onofrio, 4, 00165, Rome, Italy. FAU - De Stefano, Alessandro AU - De Stefano A AD - Department of Laboratory Medicine, "Tor Vergata" University Hospital, Rome, Italy. FAU - Calla, Cinzia AU - Calla C AD - Department of Laboratory Medicine, "Policlinico Gemelli" University Hospital, Rome, Italy. FAU - Zenobi, Rossella AU - Zenobi R AD - Department of Laboratory Medicine, "Tor Vergata" University Hospital, Rome, Italy. FAU - Dessi, Mariarita AU - Dessi M AD - Department of Laboratory Medicine, "Tor Vergata" University Hospital, Rome, Italy. FAU - Di Daniele, Nicola AU - Di Daniele N AD - Department of Internal Medicine, Nephrology and Hypertension Unit, "Tor Vergata" University Hospital, Rome, Italy. LA - eng PT - Journal Article DEP - 20140806 PL - Italy TA - J Nephrol JT - Journal of nephrology JID - 9012268 RN - 0 (Biomarkers) RN - 0LVT1QZ0BA (Homocysteine) RN - 935E97BOY8 (Folic Acid) RN - K848JZ4886 (Cysteine) RN - P6YC3EG204 (Vitamin B 12) SB - IM MH - Aged MH - Aged, 80 and over MH - Biomarkers/blood MH - Chromatography, High Pressure Liquid MH - Cysteine/*blood MH - Diabetes Mellitus, Type 2/*blood/complications MH - Disease Progression MH - Female MH - Folic Acid/*blood MH - Homocysteine/*blood MH - Humans MH - Male MH - Renal Insufficiency, Chronic/*blood/complications MH - Vitamin B 12/*blood OTO - NOTNLM OT - Chronic kidney disease OT - Cysteine OT - Folate OT - Homocysteine OT - Type 2 diabetes OT - Vitamin B12 EDAT- 2014/08/07 06:00 MHDA- 2016/06/10 06:00 CRDT- 2014/08/07 06:00 PHST- 2014/04/07 00:00 [received] PHST- 2014/07/20 00:00 [accepted] PHST- 2014/08/07 06:00 [entrez] PHST- 2014/08/07 06:00 [pubmed] PHST- 2016/06/10 06:00 [medline] AID - 10.1007/s40620-014-0126-4 [pii] AID - 10.1007/s40620-014-0126-4 [doi] PST - ppublish SO - J Nephrol. 2015 Oct;28(5):571-6. doi: 10.1007/s40620-014-0126-4. Epub 2014 Aug 6.